Pomerantz LLP is investigating Cellebrite DI Ltd. for potential securities fraud following the company's Q2 2026 financial report, which showed Annual Recurring Revenue (ARR) below guidance and a lowered full-year ARR forecast. The company also abruptly replaced its CEO, Tom Hogan, triggering a 29.18% drop in its stock price on August 13, 2026. The investigation aims to determine if Cellebrite and its executives engaged in unlawful business practices, with affected investors encouraged to join a class action lawsuit. This legal scrutiny could impact Cellebrite's reputation and investor confidence going forward.
Cellebrite DI Ltd. is under investigation following its Q2 2026 financial report and CEO change. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 14, 2026 03:11 WIB: out of 150 priced US tech stocks, 71 rose and 76 fell. Notable movers include API at USD 4.42 with a 7.54% gain and 100% buy order activity, AMAT at USD 465.00 down 6.54% with 62% buy activity, and GTLB at USD 52.53 down 6.21% with 100% buy activity. Typical hold times range from 32 to 66 days.
Applied Materials projects sustained demand for its chipmaking equipment driven by AI infrastructure growth, expecting faster spending on wafer fab equipment through 2030. The company aims to increase its market share by over 2 percentage points from...
Gordon Haskett Capital Corporation set a $105 price target for Ollie's Bargain Outlet, suggesting an 18.1% upside from its current price around $89. The company’s board approved an additional $500 million share repurchase authorization, increasing to...
FRUIT Holdings, Inc. introduced PAVE, a new protocol designed to allow AI systems to call on human judgment and authority when needed. This approach ensures that human input retains its value, authority, and attribution within AI workflows, addressin...
AngioDynamics reported a 6.9% revenue increase to $80.9 million and a narrowed adjusted loss of 4 cents per share for Q1 fiscal 2027, with strong Med Tech sales growing 13.2%. Despite beating earnings expectations and improved gross margin, the stock...
Pomerantz LLP is investigating Scholastic Corporation for potential securities fraud following the company's Q1 fiscal 2027 report, which showed an adjusted loss of $3.63 per share, missing estimates, and a 4% revenue decline to $216.8 million. The E...
